Directors

Gagan Anand

Director/Designated Partner
almost 3 years ago

Vishal Anand

Director/Designated Partner
almost 3 years ago

Patents

2019 Ncov (Sars Cov 2) Vaccine

The present invention relates to Coronavirus 2019-nCoV spike protein, polynucleotides encoding said spike protein, antibodies and vaccines for treatment or prevention of 2019-nCoV infection. One embodiment refers to isolated polynucleotide encoding a spike protein from 2019-nCoV having at least 90% identity with SEQ...

5’utr With Enhanced Protein And Peptide Expression

The present invention focuses on gene therapy and genetic vaccines, utilizing untranslated regions (UTRs) to enhance post-transcriptional protein and peptide translation within mammalian cells. Furthermore, it introduces synthetic 5' UTRs, allowing precise control of gene expression and the methodology involves mR...

Documents

Form INC-20A-25052022_signed

-24052022

Form INC-22-23052022_signed

Form ADT-1-23052022_signed

Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-23052022

Optional Attachment-(1)-23052022

Copy of written consent given by auditor-23052022

Copy of the intimation sent by company-23052022

Copy of resolution passed by the company-23052022

Copy of board resolution authorizing giving of notice-23052022

Copies of the utility bills as mentioned above (not older than two months)-23052022

CERTIFICATE OF INCORPORATION-20220428

Form SPICe MOA (INC-33)-26042022

Form SPICe AOA (INC-34)-26042022

Company Information